Catheter-Associated Urinary Tract Infection, Ascorbic Acid
Conditions
Keywords
Vitamin C, CAUTI
Brief summary
This open-label randomized trial aims at assessing the role of Vitamin C pills in the prevention of catheter-associated urinary tract infections in women undergoing elective gynecological surgeries.
Interventions
1000 mg ascorbic acid (Vitamin C) for 1 month post-op after an elective gynecological surgery.
Sponsors
American University of Beirut Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Non pregnant women at least 18 years of age visiting the Preadmission unit (PAU) or the OBGYN floor (7N), presenting for elective GYN surgery at the American University of Beirut Medical Center (AUBMC).
Exclusion criteria
* Any women with the following: 1. Nephrolithiasis 2. Congenital anomaly or neurogenic bladder 3. Allergy to ascorbic acid 4. Who require therapeutic anticoagulant medicine during the 6 weeks after surgery 5. Surgery did involve a fistula repair or a vaginal mesh removal 6. Positive Urinalysis in the PAU 7. Recurrent UTI's 8. Diabetes 9. G6PD 10. Hemochromatosis 11. Renal disorders Patients already taking Vitamin C supplementation will also be excluded from the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of participants who experienced clinically diagnosed and treated UTI. | 30 days | Urinary tract infection is diagnosed by a positive urine culture. |
Countries
Lebanon
Outcome results
None listed